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Childhood lead poisoning is characteristicaly adisease that occurs between the second andthird
years oflife, generally resulting from the child's ingestion oflead-ba paint or dust. However,
lead poisoningmayalso appearin thefirstyearoflife. The case ofa4-month-oldinfnt is report-
ed inwhich the preparation ofinfintformula in alead-soldered samovar (urn) resulted in venous
blood leadlevels ashigh as 46pgldl. Thesamovarhadbeenbrought into theUnitedStates bythe
parents while on a visit to Iran. The infant was placed on chelation therapy with parenteral
CaNa2EDTA followed by oral meso-2,3-dimercaptosuccinic acid (DMSA) and rtpenicilamine.
Thisresulted inarapidandsubstial reduction inthe bloodleadlevel. Leadpoisoningin infan-
cy may have unusual etiologies such as in wuen nsmission oflead by lead-poisoned women.
Because sources oflead poisoning in infancymaybe unusual, adetailed environmental investigag-
tion maybe nwessaryto identilj the exact source. Childrenexposedto lead in the first 2yes of
lifehave aspecialvulnerabilityto the neurotoxicityoflead,withthe riskofenduringdevelopmen-
tal handicaps. Continued public health initiatives to remove lead from the environment, in con-
junction with routine lead screening ofyoung children, will be key in meeting the goal of the
Centers for Disease Control and Prevention to eliminate childhood lead poisoning by the year




A 4-month-old male was referred to the
Children's Hospital Lead Poisoning
Treatment Program (LPTP) for manage-
ment of a venous blood lead level of 46
pg/dl. The infant had an unremarkable past
medical history. Recently the rented apart-
ment in which he lived with his parents was
scheduled to undergo deleading. The family
promptly moved to alternate housing in
another apartment building. After 2 weeks
and prior to returning to their home, the
parents requested a lead level on the infant as
a baseline before reinhabiting the apartment.
Unexpectedly, the infant's venous blood lead
level was 44 pg/dl. When evaluated by the
pediatrician, the child was asymptomatic and
there were no reports ofchange in his behav-
ior. An abdominal radiograph was negative
for radiopaque material. He was immediately
referred to the LPTP, where a repeat blood
lead was 46 pg/dl. Because ofhis young age
and uncertainty about the source ofhis lead
poisoning, he was admitted to Children's
Hospital for intravenous chelation and envi-
ronmental protection.
While the infant was hospitalized, an
environmental inspection was initiated by the
Massachusetts Childhood Lead Poisoning
Prevention Program. The family's home,
which was still undergoing deleading, was
inspected and found to have residual lead
hazards. However, theparents deniedvisiting
the apartment during its deleading. The par-
ents, who had emigrated from Iran 5 years
earlier, were asked about occupations, hob-
bies, and ethnic remedies. The mother was a
medical assistant and the father was a college
student; neither had an occupation or avoca-
tion that involved lead. They denied use of
ethnic remedies or lead-based cosmetics.
Because of the possibility that the infant's
lead exposure resulted from a source com-
mon to all familymembers, both parents and
an 11-year-old brother were tested for lead.
The father had a venous blood lead level of
<5 pg/dl, the 11-year-old had aleadlevel of8
pg/dl, and the mother's venous lead level was
29 pg/dl. Other than fatigue attributed to
caring for her infant, the mother had no
symptoms orsigns oflead intoxication.
Upon further inquiry, the mother dis-
closed that for 2 months she had been
feeding the infant formula supplemented
with breast milk; before that the child was
solely breast-fed. She denied applying any
ointments, chemicals, or metal shields to
her breasts. When asked to detail her meth-
ods of formula preparation, she stated that
she routinely used powdered formula,
reconstituting each bottle with water boiled
for 10 min in a samovar (urn) that they had
brought from Iran 6 months before. She
also admitted that since the child's birth she
had been regularly drinking tea with water
from the same urn, a practice that the father
and son did not have. She was asked to
bring the vessel in for inspection. Visual
inspection of the samovar (Fig. 1) showed
that the segments of the urn, including its
base and handles, were soldered into place.
The samovar was investigated as a source of
lead by placing 120 ml triple-distilled water
in the urn for 15 min; the water was then
decanted and analyzed for lead. The lead
concentration ofthis unboiled water, tested
by atomic absorption spectrophotometry
(model Zeeman/3030, Perkin-Elmer Corp.,
Norwalk, CT) with graphite furnace and
deuterium background correction, was
4,000 parts per billion (ppb, pg/I).
Estimating the infant's daily formula intake
at 1,000 ml, with a mean body weight of6
kg, corresponded with a daily lead intake of
greater than 600 pg/kg daily.
Upon admission to the hospital, the
infant was alert and active. There was no his-
tory of lethargy, constipation, change in
appetite, or change in behavior. Weight and
lengthwere at the 50%percentile forage. The
physical examination was unremarkable. The
admission hematocrit was 32.5%, electrolytes
and urinalysis were within normal limits, zinc
protoporphyrin was 181 pg/dl whole blood,
and serum ferritin was 35.2 ng/ml (reference
range 10-150 ng/ml). The child underwent a
5-day course ofCaNa2EDTA, 50 mg/kg/day,
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Figure 1. The samovar and its interior. Each ofthe handles is soldered into place on the vessel wall, and a
seam ofsolder alsojoinsthe base tothe vessel.
at the endofwhich his leadlevel hadfallen to
30 pg/dl. During the hospitalization, his
motherinquired aboutherabilityto continue
breast-feeding. To evaluate this, a specimen
ofher breast milk was expressed into a glass
container that had been triple-washed with
nitric acid. The lead content of the breast
milk by atomic absorption spectrophotome-
trywas <5 1ig/dl. On the basis ofthisanalysis,
the mother was advised that she could con-
tinuebreast-feeding.
The infant received further chelation as
an outpatient. He was initially prescribed
multiple courses of meso-2,3-dimercaptosuc-
cinic acid (DMSA, succimer). This was fol-
lowed by a several week course of d-penicil-
lamine. These succeeded in bringing his lead
level down to 8 pg/dl after 9 additional
months oftreatment andmonitoring. Hewas
followed in the Lead Treatment Program for
the next year. While his blood lead levels
remained low (in the range of10 pg/dl), con-
cerns were raised and subsequently verified
that the child had mild to moderate speech
delay. Early intervention was prompdy initi-
ated. There were no fiurther elevations in his
lead level. At the age of22 months, his lead
level was 12 jig/di. A venous blood lead level
attheageof3yearswas7pg/dl.
Discussion
Lead is among the most ubiquitous envi-
ronmental toxins in the world. Mined and
used extensively for more than 7,000
years, this potent heavy metal has been
cited as a contributor to such important
historical events as the fall of the Roman
Empire, epidemics of lead poisoning
among moonshiners, epidemic gout,
peripheral neuropathy in painters, and
deaths among young children (1,2).
Lead poisoning in children was first iden-
tified byTurner (3) and Gibson (4) in 1892
when cases ofencephalopathy, often fatal,
were associated with the ingestion of"white
paint" chips from old porches. In the United
States well into the 20th century, childhood
lead poisoning and paint chip ingestion
became synonymous with lead poisoning
characterized as an illness ofthe poor, found
only among children living in ghettos or
other dilapidated housing. It has been only
recently, as lead poisoning has begun to
occur from renovation ofold homes among
upper socioeconomic groups, that this dis-
ease has been able to shed its reputation as a
disease ofpoverty. In the United States, the
phaseout oflead from gasoline, paint, food,
and water over the last 20 years has dramati-
cally reduced the exposure ofAmericans to
lead and remains one of the greatest public
health successes inAmerican history (2).
Epidemiologic data from the National
Health and Nutrition Examination Survey
(NHANES) have documented the effective-
ness ofreduced lead exposure on blood lead
levels in the United States. There was a 77%
fall in mean blood lead levels between the
second and third (phase 1) NHANES stud-
ies (1976-1980 and 1988-1991) (5,6).
Recent data from phase 2 of the the third
NHANES indicate that the geometric mean
blood lead level ofchildren 1-5 years ofage
is 2.7 pg/dl (4). It is important to note that
there are little data on blood lead levels in
children less than 6 months ofage; therefore,
among infants such as the child in this case,
lead poisoning has unknown prevalence,
although congenital and neonatal lead poi-
soninghavebeenwell described.
Developmentally, childhoodleadpoison-
ing has its peak occurrence between the ages
of 18 and 24 months for avariety ofreasons
(5,7,8). First, this is an age range in which
children are the most curious, mobile, and
oral; it is also a time when adult supervision
begins to lessen. Additionally, by this age the
child has mastered the pincer grasp necessary
to pick up and mouth a paint chip. Finally,
this age range is notable for being a period
during which children become very interest-
ed in windows as a source ofplay (because
they represent an at-level table and because
ofthe toddlers' interest in observing outdoor
activities). Within homes, windows are most
likely to have flaking paint and highly
absorbable lead dust; they have been identi-
fied as an important vector for childhood
leadpoisoning (5,7,8).
Because lead paint and dust remain the
most common causes oflead poisoning in
children, the environmental assessment of a
lead-poisoned child should begin with an
investigation ofthe child's residence (9). In
this case, there was no lead in the alternate
housing. The familyhomedidhaveleadhaz-
ards, but the parents denied entering the
home. Also, the young age of the child
meant he had neither the mobility nor the
dexterity to grasp a paint chip or mouth a
dust-laden object. Nonetheless, in a review
ofthe etiologies oflead poisoning in the first
year oflife, we found that epidemiologically
the most common cause was household ren-
ovation (10). Another potential source of
lead in the first 6 months oflife is congenital
lead poisoning. The kinetics oflead in preg-
nancy are such that it is efficiendy transmit-
ted across the placenta; fetal blood lead levels
are 80-100% those ofthe mother (11,12).
The postnatal rate ofdecline in blood lead
levels among congenitally lead-poisoned
neonates has not been defined. Theoretically,
the rapid growth and bone development of
the infant should promote a rapid fall in
blood lead levels. In this case, the finding of
an elevated lead level in the mother was in
fact strongly suggestive of congenital lead
poisoningas anetiology(13-15).
Other potential sources oflead poison-
ing in infants are the use of folk remedies
and lead-contaminated water. Folk reme-
dies, nutritional supplements, and cosmetics
may be very high in lead (16,1X. Water is a
component ofbackground daily lead expo-
sure but can also occasionally result in frank
lead poisoning. A phenomenon occurring
almost solely in infants who are fed pow-
dered or concentrated formula (because
these require the addition oflarge amounts
ofwater), lead poisoning from contaminated
water has been previously described (18,19).
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In our own series, 24% of lead poisoning
cases were due to water contamination (10).
We measured lead concentrations in water
samples as high as 200,000 ppb, either from
water that was placed in a lead-containing
vessel, from excessive boiling, or from use of
lead-contaminated tap water. The EPA has
recently established a maximum contami-
nant level ofzero for lead in water, with an
action level of 15 ppb. In a recent national
evaluation ofwater supplies, the EPA found
that more than 130 municipalities exceeded
the action level (20).
Lead intoxication in infants from water
has several unique features. First, with the
administration offormula daily, this vector
guarantees a high daily intake oflead for a
protracted period of time. Second, lead
absorption from the gastrointestinal tract is
inversely related to age; an estimated
30-50% ofingested lead is absorbed by the
gastrointestinal tract of a child versus
approximately 10% in an adult (21). This
observation implies that lead absorption
from the gut would be maximal in the first
months of life. Finally, because absorption
of lead is inversely related to particle size,
lead in water is more absorbable than lead
from paint or dust. The quantity of lead
administered by this route can be enor-
mous. For example, a 4-month-old child
would drink approximately 1,000 ml of
water daily if given powdered or concen-
trated formula. Ifthat water has a lead con-
centration of 100 ppb, a concentration
exceeded in many U.S. communities, the
child's daily intake of lead would be 100
pg. At an average body weight of6 kg, the
child would be exposed to more than 15
pg/kg oflead daily. Positive lead balance in
infants is associated with daily intakes of
greater than 5 pg/kg (22). Given the slow
rate ofelimination oflead from the body (a
half-life of 20 years) (23,24), there would
be accumulation such by the first birthday,
the lead burden would be substantial, with
the child having been exposed to 36,500 pg
oflead from water alone.
In the case under discussion, the source
of lead was traced to an imported cooking
vessel. Lockitch et al. (19) described a simi-
lar case of an infant who presented with
seizures in association with a blood lead
level of 155 pg/dl as a result of parents
using a samovar. That case, like this one,
illustrates that alternate sources including
lead-glazed ceramics and cooking vessels
must be considered in the evaluation of
infants with lead poisoning (25).
Early signs oflead poisoning in children
arehighlyvariable and can beverydifficult to
discern in the young nonverbal child.
Children can be completely asymptomatic
across a wide range of blood lead levels.
Typicallychildren have no overt signs oftoxi-
city until blood lead levels exceed 25-30
pg/dl. Early signs oftoxicity are nonspecific
and may include sleeping difficulties,
decreased appetite, and hyperactivity (26,24.
Oncebloodleadlevelsexceed 50 pg/dl, mani-
festations become more obvious, e.g., marked
irritabilityandanorexia. Seizures mayoccurat
blood lead levels as low as 50-60 pg/dl (28).
When lead levels exceed 80-100 pg/dl, frank
encephalopathy with lethargy, seizures, cere-
bral edema, anddeath canoccur (29,30).
Because children can remain asympto-
matic for extended periods of time, the
practice ofroutine lead screening has assist-
ed in reducing the incidence ofsevere lead
poisoning by identifying children as their
exposure is just beginning and by prevent-
ing exposure in siblings and playmates.
Interestingly, because lead screening does
not typically begin until the child is at least
6 months old, this infant's lead poisoning
might not have been discovered if the
mother had not requested lead screening.
Severe lead poisoning is treated with
hospitalization and chelation therapy (9).
Chelation therapy has several potential
advantages. First, it has been proven to
reduce the mortality associated with lead
poisoning. Second, it can rapidly reduce the
overall lead burden bypromoting lead elim-
ination; with lead's profound biological per-
sistence, minimal elimination occurs in the
absence of chelation. Third, chelation can
more rapidly ameliorate toxic effects oflead
such as impaired vitamin D activation,
diminished nerve conduction velocity, and
hematologic toxicity (as manifested by ele-
vated erythrocyte protoporphyrin) (31,32).
Finally, there is evidence, which requires
further validation, that chelation may mini-
mize the extent of neurodevelopmental
injury the childwill sustain (33).
Until recently, theonlychelators available
for moderate to severe lead poisoning were
NaCa2EDTA and 2,3-dimercapto-1-
propanol (dimercaprol, BAL). Because these
are parenterally administered agents, hospital-
ization is usually necessary. In 1991, DMSA
became thefirst oral chelatorapproved forthe
treatment ofmoderate lead poisoning in chil-
dren (34,35). This chelator has proven to
have a favorable profile ofsafety and efficacy,
offering the possibility ofoutpatient manage-
ment (36,34. DatabyGraziano et al. (34,35)
suggest that DMSA has an efficacy compara-
ble to EDTA and can serve as an oupatient
alternative to EDTA chelation. However, in
cases such as this, where the source ofexpo-
sure is undear, hospitalization may be neces-
sary to prevent ongoing exposure. d-
Penicillamine is an oral lead chelator that has
been used since the 1970s for the treatment
oflead poisoning (38). Like DMSA, it is also
very efficacious in reducing blood lead levels
in children (39). However, because it is not
approved by the Food and Drug
Administration for this indication and has a
significant side effect profile, there remains
considerable reluctance to use thischelator.
The natural history of blood lead levels
after chelation therapy, as demonstrated in
this case, is one offrequent rebound in blood
lead levels, representing continued diffusion
oflead from bone and soft tissues back into
blood. With the goal of chelation therapy
being to lower and maintain the lead level
below 10-15 pg/dl in this case, repeated
courses were necessary. Childhood lead poi-
soning is therefore achronic illness forwhich
treatment may be needed for ayear or more.
Efficient, successful management requires a
multidisciplinary approach that includes
pediatricians, toxicologists, community
advocates, andhousingspecialists.
The lead poisoning unexpectedly found
in the mother presented several manage-
ment difficulties. First, the finding suggest-
ed that the child was a victim ofcongenital
lead poisoning. This was unlikely, given the
historythe mother provided ofnot drinking
tea from her samovar until the child was
born. A second concern was that the moth-
er probably acquired a substantial lead bur-
den during her childbearing years. This had
implications for future children. We felt it
advisable to counsel the mother against hav-
ing another child for at least a year, assum-
ing that in such a period oftime her blood
lead concentration would fall, thereby mini-
mizing the extent oftransplacental lead dif-
fusion. Finally, the safety of continued
breast-feeding became a concern. Elevations
in the concentration of lead in breast milk
may normally occur in lactating women
either from the lead mobilization that
accompanies the bone mobilization ofpreg-
nancy or from low-grade environmental
exposure duringpregnancy (40,41).
Studies of the diffusion of lead into
breast milk have produced somewhat incon-
sistent results. Milk to plasma ratios oflead
in milk range from 0.1 to 0.3 (42).
Nahimira et al. (43) found ahigh linear cor-
relation (r= 0.88) between blood and breast
milk lead levels when maternal blood lead
was greater than 40 pg/dl (43), but others
have not found such a correlation (44). In
an examination ofthis mother and in a sim-
ilar case, we found that with women who
have blood lead levels <35 pg/dl there is
minimal excretion of lead into breast milk
(45). We were therefore able to counsel this
mother thatbreast-feeding could continue.
Among the toxicities of lead, the effect
with the greatest potential long-term impact
is injury to the developing brain (4648). It
is the neurodevelopmental toxicity of lead
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thatled to its recognition as ahazardofgreat
public health impact. Over the last 20 years,
the lead levels at which these neurodevelop-
mental toxicities can occurhas been lowered,
as rigorous longitudinal studies have demon-
strated such effects at low blood lead levels.
Studies by Baghurst et al. (49,50), Bellinger
et al. (51-54), Needleman et al. (55-59),
and others have firmly established that lead
neurotoxicity may occur in children who
have blood lead levels as low as 10 pg/dl (2).
The infant in this case was therefore in a
high risk category for neurodevelopmental
sequelae. It is notable that at an early age
concerns were raised about his development.
Data by Bellinger et al. (51-54) and others
have suggested that cognitive performance
among school-aged children who have high
levellead exposure earlyin life is bestpredict-
ed by the blood lead level at the age of 24
months. In the case under discussion, the
child's residual lead burden plus ongoing
background environmental exposures result-
ed in a lead level ofgreater than 10 pg/dl at
the age of 22 months, placing the child at
risk for long-term neurodevelopmental
weaknesses (53).
This unfortunate case exemplifies the
multifaceted nature ofchildhood lead poi-
soning: lead epidemiology, unusual lead
sources, the kinetics oflead in young chil-
dren, chelation therapy, neurodevelopmental
consequences, and lead kinetics in lactating
women. In 1991, the Centers for Disease
Control and Prevention announced a 20-
year goal for the elimination of childhood
lead poisoning in the United States. While
the incidence of childhood lead poisoning
continues to fall due to the combination of
environmental reduction and lead screening,
the approximately 1 million lead-poisoned
American children remaining (2) are a clear
indication that the issues which arose in this
casewill continue to occur.
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